Peter S. Lawrence, J.D. || President and CEO, Cardurion Pharma

Mr. Lawrence joined Cardurion as President, Chief Executive Officer and a board member in March of 2020. Mr. Lawrence brings more than 20 years of experience as a life sciences executive and investor with a track record of company building, deal making and operational leadership. He previously served for almost 14 years as President and Chief Operating Officer of ArQule, Inc., a biotechnology company located in Burlington, MA, focused on the development of novel therapies for cancers and rare diseases. In addition to his strategic role as president of ArQule, Mr. Lawrence oversaw the company’s R&D and manufacturing operations as well as its corporate and business development, new product planning, IT, legal and IP functions. Concurrently, he served as principal financial officer for ArQule and in that role helped raise over $350 million through six public financings. Additionally, Mr. Lawrence facilitated collaborations with ArQule’s pharmaceutical and biotechnology partners, overseeing partnerships with a total value in excess of $1 billion and helped lead ArQule’s sale to Merck for $2.7 billion in January 2020. Before joining ArQule, Mr. Lawrence was a founder and general partner of Pod Venture Partners and previously was an equity partner at Mintz Levin. He holds a degree in history and Russian studies from Amherst College and a J.D. from Boston University School of Law.